Full record
75% rightmarketsBristol Myers Squibb (BMY) shares reach $87.
A scored prediction by Tom Nash, made on .
Scored prediction
75% rightmarkets“which gives us eighty seven dollars per share right here which is 33 upside versus the current 65 dollar price”
Bristol Myers Squibb (BMY) shares reach $87.
- Made on
- 2021-06-03
- Outcome
- 75% right
- Importance
- 3 / 5
- Effect on score
- +2.94
What counted as right
- Status
- resolved
- Settled on
- 2024-06-03
BMY trades at or above $87.00 per share (closing price, split- and not dividend-adjusted) at any point on or before 2024-06-03.
Miss. The peak available in the window, $81.435, is about 6.4% below the $87.00 target, and the maximum daily close is bounded by that same figure, so the monthly series is sufficient. The criterion's 'not dividend-adjusted' instruction is satisfied: the series used reports nominal close ($71.95 for 2022-12) separately from the dividend-adjusted value ($60.94), and the nominal figures are the ones cited. Cross-checked against NYSE consolidated monthly OHLC from the Interactive Brokers market-data feed, which matched (2022-12 high 81.44, 2022-11 close 80.28). Note there is no tolerance band in this criterion, unlike the 2021-05 Tesla record, so the roughly 6% shortfall is a straight miss. No conflicting evidence found. resolved_on is the deadline date.
Sources
How To Inflation Proof Your Portfolio [Finding The Best Inflation Proof Investments In 2021]
YouTube - Tom Nash (@TomNashTV) ·
Evidence of what happened
Monthly OHLC for BMY (nominal prices, not dividend-adjusted, as the criterion specifies) over 2021-06 through 2024-06: the highest price reached at any point in the window was $81.435 intraday in December 2022. The highest monthly close was $80.28 (November 2022). BMY never traded at or above $87.00 on or before 2024-06-03.
Exact data endpoint queried (10-year monthly series). The December 2022 high of $81.435 is also the maximum high across the whole ten-year series, so it is BMY's peak nominal price in the modern record, not merely the window peak. BMY declined heavily afterwards, with the stock in the $39-$52 range through most of 2024.
Corrections
No public corrections.
Effect on the score
+2.94- How sure they sounded
- 85%
- Outcome
- 75% right
- Importance
- 3 / 5
This page shows the scored prediction as published; the site doesn't recompute or adjust the score.
Where this came from
Bristol Myers Squibb (BMY) shares reach $87.- Methodology version
- v1.0.0
- Last computed
- August 2, 2026
- Made on
- 2021-06-03
How this profile was built
Scored by independent judges
Predictions gathered and sourced
Independently verified against sources